Premium Drug Discovery Services

Our clients are seeking answers in their quest to discover effective treatments for patients. Finding these answers is our mission as a CRO. Our method is to accelerate the drug discovery process with the widest possible range of assays and services but also to maintain an integrated view of the journey to a lead drug candidate. We strive to provide excellent data, delivered in a timely, collaborative manner by outstanding scientists. Who are we? We’re your partner.
 
Let’s Discover Together.

What people are saying

Reaction Biology Europe has provided their services for several projects with us, including establishing an orthotopic tumor model and PK/PD studies. I was very impressed, not only by their level of expertise and professionalism but also by their enthusiasm and drive to deliver. The insightful advice they provide has been instrumental to our successes and their collegial and “can do” attitude make them a pleasure to team up with!

Prof Matthias Klugmann
Scientific Expert at Boehringer-Ingelheim

I have worked with Reaction Biology Europe and Reaction Biology Corp. for more than 5 years on several interesting projects. These have ranged from routine enzyme screening to more complex kinome-scan and in-cell target engagement work. The results of these endeavors have led to a series of top-tier publications. This coupled with exceptional customer service means I have no hesitation to recommend Reaction Biology Corp. and Reaction Biology Europe as research partners.

Dr Christopher Asquith
Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill

Reaction Biology Europe has provided their service for numerous projects with us, especially on multiple kinase assays (under the name ProQinase) which have guided our way through drug development. I was very impressed not only by their level of expertise and professionalism but also by their enthusiasm and drive to deliver without delay. The insightful advice they provide has been instrumental to our successes, and the reproducibility, quality, and reporting of the results have been outstanding throughout the many years we have been working together.

Dr Laurent Meijer
Chair & Chief Scientific Officer at Perha Pharmaceuticals & ManRos Therapeutics

We have worked with Reaction Biology Europe for 3 years on in vivo drug development assays. They have provided their services from routine PK through efficacy and custom BLI studies in tumor models, consistently generating high-quality results that guided our development process. Their expertise, responsiveness, and professionalism make Reaction Biology stand out from among the usual CROs, and we are happy to recommend them as research partners.

Dr Oliver Thorn-Seshold
Department of Pharmacy, Ludwig-Maximilian's University of Munich (LMU)

Meet Us at Our Next Event

San Diego view
Virtual from San Diego, CA, USA
-

Drug Discovery Chemistry

Learn about strategies for small molecule compound development in the targeted approach.

Join us
Virtual from Central Europe

EFMC MedChemBioOnline Webinar

Join the high profile webinar about the epigenetic drug discovery with a med chem twist.

Join us
Boston, MA, USA & Virtual
-

Discovery on Target

The industry’s preeminent event on novel drug targets and technologies

Join us
Liverpool, UK
-

ELRIG Drug Discovery

After the Storm: Re-Connect, Re-Invent, Re-Imagine. Europe’s largest meeting for life sciences…

Join us
San Diego, CA, USA
-

Immuno Series US

Discuss the latest strategies to harness the immune system for the development of innovative…

Join us
London, UK
-

Discovery Series UK

An in-person event to meet our scientists heading our biophysical and KRAS-related service units…

Join us
London, UK

Immuno Series UK

Join us at our first in-person meeting this year to explore our immuno-oncology platform.

Join us

Latest News

COVID-19 /SARS-CoV2 update

Dear customers,

all Reaction Biology research facilities are and remain fully operational under safe work environment guidelines. Our business will not close due to lockdown restrictions in Europe. Our sales staff and business development team are happy to discuss any project with you. Please reach out!

Cooperation with 4HF Biotec to provide new Bioinformatic Cell Service

In cooperation with the bioinformatics firm 4HF Biotec, we announce the offering of a combination of the ProLiFiler cell panel screening service with 4HF‘s bioinformatic evaluation of the drug‘s profile.

ProQinase is now Reaction Biology Europe

ProQinase rebranding into Reaction Biology Europe GmbH was performed completing the process of acquiring ProQinase. As this only represents a change of name, all contracts with former ProQinase remain valid and binding. All ProQinase products and services are continued and available within the Reaction Biology portfolio.